• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷尼替丁含蒙脱石和 Eudragit E-100 的控释制剂。

Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100.

机构信息

Discipline of Inorganic Materials and Catalysis, Central Salt and Marine Chemicals Research Institute, Council of Scientific and Industrial Research (CSIR), Bhavnagar, Gujarat, India.

出版信息

Drug Dev Ind Pharm. 2010 Sep;36(9):1046-53. doi: 10.3109/03639041003642073.

DOI:10.3109/03639041003642073
PMID:20545505
Abstract

AIM

The objective of this work was to illustrate the suitability of montmorillonite (MMT) as a drug delivery carrier, by developing a new clay-drug composite of ranitidine hydrochloride (RT) intercalated in MMT.

METHODS

The MMT-RT composite was prepared by ion-exchange process. X-ray diffraction and Fourier transform infrared spectra were employed to confirm the intercalation of RT in the MMT interlayers. The prepared MMT-RT hybrid was coated with cationic polymer Eudragit E-100 by oil-in-water solvent evaporation method. The release processes of RT from MMT-RT and MMT-RT/Eudragit E-100 were monitored under in vitro condition in the gastric fluid.

RESULTS

X-ray diffraction and Fourier transform infrared spectra analysis indicated the intercalation of RT molecules within the clay lattice. The in vitro release studies showed that MMT-RT released RT in a controlled manner. In the case of MMT-RT/Eudragit E-100, both the release rate and the release percentages noticeably increased in the presence of Eudragit E-100, because of its effective exchange with intercalated RT molecules. The release kinetics followed parabolic diffusion mechanism.

CONCLUSION

MMT has great potential as a drug delivery carrier with various scenarios. The dosage of the MMT-RT/Eudragit E-100 can be in the tablet form. The hybrid material and polymer-coated hybrids are microparticles.

摘要

目的

本工作旨在通过制备插层有盐酸雷尼替丁(RT)的新型粘土-药物复合材料,说明蒙脱石(MMT)作为药物载体的适用性。

方法

通过离子交换法制备 MMT-RT 复合材料。采用 X 射线衍射和傅里叶变换红外光谱来确认 RT 插层进入 MMT 层间。通过油包水溶剂蒸发法,用阳离子聚合物 Eudragit E-100 对制备的 MMT-RT 杂化物进行涂层。在体外条件下,在胃液中监测 RT 从 MMT-RT 和 MMT-RT/Eudragit E-100 中的释放过程。

结果

X 射线衍射和傅里叶变换红外光谱分析表明 RT 分子插层进入粘土晶格。体外释放研究表明 MMT-RT 以控制方式释放 RT。对于 MMT-RT/Eudragit E-100,由于与插层 RT 分子的有效交换,Eudragit E-100 的存在明显增加了释放速率和释放百分比。释放动力学遵循抛物线扩散机制。

结论

MMT 作为一种具有多种应用场景的药物载体具有很大的潜力。MMT-RT/Eudragit E-100 的剂量可以制成片剂形式。混合材料和聚合物涂层的混合材料是微粒。

相似文献

1
Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100.雷尼替丁含蒙脱石和 Eudragit E-100 的控释制剂。
Drug Dev Ind Pharm. 2010 Sep;36(9):1046-53. doi: 10.3109/03639041003642073.
2
Preparation of Eudragit E100 microspheres by modified solvent evaporation method.采用改良溶剂蒸发法制备聚丙烯酸树脂E100微球。
Acta Pol Pharm. 2011 Nov-Dec;68(6):975-80.
3
Controlled release of donepezil intercalated in smectite clays.插层于蒙脱石粘土中的多奈哌齐控释制剂。
Int J Pharm. 2008 Jul 9;359(1-2):198-204. doi: 10.1016/j.ijpharm.2008.04.012. Epub 2008 Apr 14.
4
Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate.蒙脱石作为一种药物递送系统:马来酸噻吗洛尔的插层及体外释放
Int J Pharm. 2009 Jun 5;374(1-2):53-7. doi: 10.1016/j.ijpharm.2009.03.004. Epub 2009 Mar 19.
5
Layered bionanocomposites as carrier for procainamide.层状生物纳米复合材料作为普鲁卡因胺的载体。
Int J Pharm. 2010 Mar 30;388(1-2):280-6. doi: 10.1016/j.ijpharm.2010.01.002. Epub 2010 Jan 13.
6
A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.基于壳聚糖和蒙脱石的 pH 敏感纳米复合微球具有体外降低突释效应。
Drug Dev Ind Pharm. 2010 Sep;36(9):1106-14. doi: 10.3109/03639041003677798.
7
Bifunctional capsular dosage form: novel fanicular cylindrical gastroretentive system of clarithromycin and immediate release granules of ranitidine HCl for simultaneous delivery.双功能胶囊剂型:新型扇形圆柱形克拉霉素胃滞留系统及盐酸雷尼替丁速释颗粒用于同步给药。
Int J Pharm. 2014 Jan 30;461(1-2):310-21. doi: 10.1016/j.ijpharm.2013.11.053. Epub 2013 Dec 3.
8
Controlled release and antibacterial activity chlorhexidine acetate (CA) intercalated in montmorillonite.载醋酸洗必泰(CA)的蒙脱土的控释和抗菌活性。
Int J Pharm. 2009 Dec 1;382(1-2):45-9. doi: 10.1016/j.ijpharm.2009.08.004. Epub 2009 Aug 8.
9
Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.纳米黏土杂化物及其在有机聚合物中的分散体的药物释放特性。
Int J Pharm. 2011 Jul 29;414(1-2):321-31. doi: 10.1016/j.ijpharm.2011.05.028. Epub 2011 May 12.
10
Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.双层和三层片剂药物传输系统,用于口服释放可溶性和难溶性药物的持续释放。
Drug Dev Ind Pharm. 2010 Aug;36(8):903-16. doi: 10.3109/03639040903585119.

引用本文的文献

1
Interactions between Active Ingredient Ranitidine and Clay Mineral Excipients in Pharmaceutical Formulations.药物制剂中活性成分雷尼替丁与粘土矿物辅料之间的相互作用。
Materials (Basel). 2020 Dec 6;13(23):5558. doi: 10.3390/ma13235558.
2
Polymer Selection for Hot-Melt Extrusion Coupled to Fused Deposition Modelling in Pharmaceutics.用于制药中热熔挤出与熔融沉积建模相结合的聚合物选择
Pharmaceutics. 2020 Aug 22;12(9):795. doi: 10.3390/pharmaceutics12090795.
3
Investigation of the potential application of sodium bentonite as an excipient in formulation of sustained release tablets.
膨润土钠作为缓释片制剂辅料的潜在应用研究。
Asian J Pharm Sci. 2017 May;12(3):259-265. doi: 10.1016/j.ajps.2017.01.004. Epub 2017 Jan 24.
4
A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride.一种基于脂质体包裹蒙脱石的新型离子交换载体,用于盐酸倍他洛尔的眼部递送。
Int J Nanomedicine. 2017 Mar 2;12:1731-1745. doi: 10.2147/IJN.S122747. eCollection 2017.
5
Effect of dinitolmide intercalated into Montmorillonite on E. tenella infection in chickens.二硝苯甲酰胺插层蒙脱石对鸡感染艾美耳球虫的影响。
Parasitol Res. 2014 Mar;113(3):1233-8. doi: 10.1007/s00436-014-3762-7. Epub 2014 Jan 31.